Senseonics Holdings Inc (SENS)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$9.63-2.73%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
Broken: Primary pillar broken — Operating income improves from -$31.8M in 2026-Q1: metric not reported.
Senseonics is growing revenue from $35M in 2025 to about $62M in 2026. Gross margin is improving to about 56.5% in 2026. The company is expanding through acquisitions to boost growth. These steps could lead to a stronger business.
Senseonics is still loss-making with operating income worsening to -$31.8M in 2026-Q1. Revenue growth is uneven and recent selloff shows investor doubts. Profitability and cash flow remain weak risks.
The price is about 37% above our fair value near $4. Analysts expect 81% revenue growth. Our view is cautious given losses and uneven progress on profitability.
Breaks if: Gross margin falls below 55% in FY26
Breaks if: No meaningful acquisitions or failed integration in 2026
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a speculative growth opportunity. The company is currently loss-making but is focused on expanding revenue and improving margins, which could support future growth.
The market appears to have priced in a low level of confidence, as indicated by the expectations gap. Valuation is at a premium compared to peers, suggesting that investors are cautious about future performance.
Management has shown commitment to expanding revenue and improving gross margins, with recent financial performance indicating strong growth in these areas. However, the company has a history of earnings misses, which raises near-term risk.
The long-term thesis hinges on the company's ability to maintain momentum in revenue growth and margin improvement while navigating potential economic headwinds. Key factors include the performance of sector bellwethers and the overall economic environment.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. The latest earnings miss has negatively impacted the outlook. Recent financial performance remains weak, which adds to the concerns about the company's trajectory.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Senseonics is focusing on growth through strategic acquisitions.
Breaks if: Operating loss worsens beyond -$31.8M in next 4 quarters
Breaks if: Revenue falls below $60M in FY26
Over the next 1 to 3 years, SENS's success will depend on its operational execution and external market conditions. Not investment advice.